User talk:Katefremov

Welcome!
Hello, Katefremov, and welcome to Wikipedia! My name is Elysia and I work with the Wiki Education Foundation; I help support students who are editing as part of a class assignment.

I hope you enjoy editing here. If you haven't already done so, please check out the student training library, which introduces you to editing and Wikipedia's core principles. You may also want to check out the Teahouse, a community of Wikipedia editors dedicated to helping new users. Below are some resources to help you get started editing. If you have any questions, please don't hesitate to contact me on my talk page. Elysia (Wiki Ed) (talk) 16:43, 6 September 2019 (UTC)

Very Long-Chain Acyl-coenzyme A Dehydrogenase Deficiency (VLCADD) is a recessive fatty-acid metabolism disorder that  inhibits and/or prevents the body from oxidizing certain fatty acids [5]. The Acyl-CoA Dehydrogenase Very Long Chain (ACADVL) gene controls the production of very long-chain-acyl-dehydrogenase (VLCAD) and therefore interferes with normal metabolic breakdown of fatty acids [6]. Due to the accumulation of fatty acids in the body, VLCADD can cause fatal symptoms if not treated promptly. Depending on the severity of the disease, signs and symptoms can appear as early as infancy or as late as adulthood and are treated on a personal basis [6]. On average, Very Long-Chain Acyl-coenzyme A Dehydrogenase Deficiency, affects more than 1 in 75,000 newborns [8].

Very Long-Chain Acyl-coenzyme A Dehydrogenase Deficiency (VLCADD) is a recessive fatty-acid metabolism disorder that  inhibits and/or prevents the body from oxidizing certain fatty acids [9]. The Acyl-CoA Dehydrogenase Very Long Chain (ACADVL) gene controls the production of very long-chain-acyl-dehydrogenase (VLCAD) and therefore interferes with normal metabolic breakdown of fatty acids [6]. Due to the accumulation of fatty acids in the body, VLCADD can cause fatal symptoms if not treated promptly. Depending on the severity of the disease, signs and symptoms can appear as early as infancy or as late as adulthood and are treated on a personal basis [6]. On average, Very Long-Chain Acyl-coenzyme A Dehydrogenase Deficiency, affects more than 1 in 75,000 newborns [8].